{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T09:53:55Z","timestamp":1769853235180,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jaad.2016.04.005","type":"journal-article","created":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T09:24:21Z","timestamp":1466414661000},"page":"287-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Serious infections in hospitalized patients with psoriasis in the United States"],"prefix":"10.1016","volume":"75","author":[{"given":"Derek Y.","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2016.04.005_bib1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","article-title":"Psoriasis prevalence among adults in the United States","volume":"70","author":"Rachakonda","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.04.005_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.it.2006.12.005","article-title":"The pathogenic role of tissue-resident immune cells in psoriasis","volume":"28","author":"Boyman","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaad.2016.04.005_bib3","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jaad.2005.10.057","article-title":"Innate and adaptive immunity and the pathophysiology of psoriasis","volume":"54","author":"Gaspari","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.04.005_bib4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1365-2133.2005.06645.x","article-title":"Psoriasis: dysregulation of innate immunity","volume":"152","author":"Bos","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.04.005_bib5","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/S0149-2918(03)80313-2","article-title":"An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis","volume":"25","author":"Weinberg","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2016.04.005_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/bjd.12663","article-title":"Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials","volume":"170","author":"Schmitt","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.04.005_bib7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jaad.2010.09.734","article-title":"The risk of infection and malignancy with tumor\u00a0necrosis factor antagonists in adults with psoriatic\u00a0disease: a systematic review and meta-analysis of randomized\u00a0controlled trials","volume":"64","author":"Dommasch","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.04.005_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archdermatol.2011.2768","article-title":"Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: Patients ineligible vs eligible for\u00a0randomized controlled trials","volume":"148","author":"Garcia-Doval","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2016.04.005_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001","volume":"289","author":"Mokdad","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2016.04.005_bib10","unstructured":"HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov\/nisoverview.jsp."},{"key":"10.1016\/j.jaad.2016.04.005_bib11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jaad.2008.08.034","article-title":"Potential misclassification of patients with psoriasis in electronic databases","volume":"59","author":"Icen","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.04.005_bib12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/pds.3447","article-title":"Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009","volume":"22","author":"Asgari","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaad.2016.04.005_bib13","unstructured":"Age and Sex Composition in the United States. United States Census Bureau. https:\/\/www.census.gov\/population\/age\/data\/cps.html. 2013."},{"key":"10.1016\/j.jaad.2016.04.005_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2015.5240","article-title":"Costs of Care for Hospitalization for Pemphigus","author":"Hsu","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2016.04.005_bib15","unstructured":"Centers for Disease Control and Prevention. 2013 NCHS urban-rural classification scheme for counties. http:\/\/www.cdc.gov\/nchs\/data_access\/urban_rural.htm. 2013."},{"key":"10.1016\/j.jaad.2016.04.005_bib16","unstructured":"United States Department of Labor. Consumer price index. http:\/\/www.bls.gov\/cpi\/. 2014."},{"key":"10.1016\/j.jaad.2016.04.005_bib17","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bjd.12214","article-title":"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up","volume":"168","author":"Papp","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.04.005_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaad.2010.12.005","article-title":"Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL","volume":"66","author":"Gordon","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.04.005_bib19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jamadermatol.2014.3593","article-title":"Economic burden of psoriasis in the united states: A systematic review","volume":"151","author":"Brezinski","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2016.04.005_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2016.03.048","article-title":"The Inpatient Burden of Psoriasis in the United States","volume":"75","author":"Hsu","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.04.005_bib21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaad.2008.09.022","article-title":"The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004","volume":"60","author":"Kurd","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.04.005_bib22","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s10067-014-2763-3","article-title":"Psoriasis and psoriatic arthritis in African-American patients\u2013the need to measure disease burden","volume":"34","author":"Kerr","year":"2015","journal-title":"Clin Rheumatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216300342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216300342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:39:43Z","timestamp":1759271983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962216300342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0190962216300342"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.04.005","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serious infections in hospitalized patients with psoriasis in the United States","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}